Nurse Practitioner, Family · San Antonio, TX
NPI
1033775572
Since 2019
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
5107 Medical Dr
San Antonio, TX, 78229
Phone (210) 614-8612
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$3.2M
5,116 prescriptions
Company payments, 2025
$3,859
From 30 companies
Medicare prescription drug claims, 2024
In 2024, the drug Kalicia Christie prescribed most often to Medicare patients was Levothyroxine Sodium, with 399 prescriptions and refills. In total Kalicia Christie wrote 5,116 Medicare prescriptions that cost $3.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-06-11.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Levothyroxine Sodium Generic | 399 | 1,086 | 170 | $4,589 |
| Ozempic Semaglutide | 376 | 521 | 103 | $482K |
| Mounjaro Tirzepatide | 330 | 373 | 76 | $388K |
| Atorvastatin Calcium Generic | 277 | 807 | 126 | $2,395 |
| Rosuvastatin Calcium Generic | 162 | 455 | 75 | $2,382 |
| Jardiance Empagliflozin | 157 | 353 | 65 | $198K |
| Metformin Hcl Generic | 142 | 401 | 72 | $1,201 |
| Metformin Hcl Er Metformin Hcl | 140 | 401 | 64 | $1,360 |
| Trulicity Dulaglutide | 137 | 219 | 47 | $208K |
| Farxiga Dapagliflozin Propanediol | 119 | 253 | 41 | $139K |
| Glimepiride Generic | 117 | 337 | 50 | $1,172 |
| Lisinopril Generic | 110 | 296 | 50 | $891 |
| Losartan Potassium Generic | 95 | 272 | 47 | $965 |
| Synthroid Levothyroxine Sodium | 86 | 224 | 32 | $7,572 |
| Humalog Kwikpen U-100 Insulin Lispro | 83 | 164 | 30 | $29K |
Brand drugs: 2,506 claims; generic drugs: 2,254 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kalicia Christie $3,859 ($3,859 in general payments such as food, travel and fees) from 30 companies. The largest payer was Novo Nordisk Inc with $413.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 21 | $413 |
| Lilly USA, LLC LLY | 20 | $368 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 19 | $355 |
| Corcept Therapeutics CORT | 14 | $293 |
| Mannkind Corporation MNKD | 20 | $275 |
| Amgen Inc. AMGN | 18 | $258 |
| Novartis Pharmaceuticals Corporation NVS | 20 | $212 |
| Sequel Med Tech, LLC | 9 | $197 |
| Dexcom, Inc. DXCM | 4 | $177 |
| Xeris Pharmaceuticals, Inc. | 9 | $166 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.